Onconetix, Inc. Other Notes Payable, Current
Onconetix, Inc. (ONCO) had Other Notes Payable, Current of $9.33 million as of 2024-12-31, per its 10-K filed 2025-06-02.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Notes Payable, Current
us-gaap:OtherNotesPayableCurrent · last filed 2025-06-02
- 2024-12-31: Other Notes Payable, Current $9.33M.
- 2024-09-30: Other Notes Payable, Current $9.84M.
- 2023-12-31: Other Notes Payable, Current $9.62M.
| Period end | Other Notes Payable, Current |
|---|---|
| 2024-12-31 | $9.33M 10-K · filed 2025-06-02 |
| 2024-09-30 | $9.84M 10-Q · filed 2024-12-10 |
| 2023-12-31 | $9.62M 10-K · filed 2025-06-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |